Genetics

People who primarily investigate genes and inheritance patterns, counsel people about genetic testing and/or collect genetic specimens.

Alexis Oddi

Data Science Resrch Specialist

Alexis is a graduate of the University of California, Berkeley, where she received her Bachelor’s degree in Data Science and a concentration in Urban Science. As an Undergraduate Research Assistant, Alexis studied the impact of the technology industry on housing in the Bay Area. Her specialities include data mapping and data visualization, and she is deeply interested in the intersections of neurology, data science, and social justice.

Taru Flagan, PhD

Research Scientist

Taru received a bachelor of science degree in cognitive neuroscience from the University of California, San Diego and completed a PhD degree in psychology in the Self-Regulation Laboratory at the University of Texas at Austin in 2016. She joined the Dementia Imaging Genetics Lab in 2017 to support neuroimaging methods for understanding the underlying biology of genetic variants of frontotemporal dementia.

Claire Clelland, MD, PhD

Assistant Professor

Claire Clelland, MD, PhD, is a clinician-scientist in the UCSF Department of Neurology at the Weill Institute for Neurosciences, where she leads the Clelland Laboratory at the UCSF Edward and Pearl Fein Memory and Aging Center.

Ana Tyler

Program Manager

Ana Tyler, JD, MA, received her undergraduate degree from The Ohio State University and her law degree with a concentration in health law and policy and master’s degree in bioethics from Case Western Reserve University. After completing a fellowship in Clinical Ethics from Sutter Health (California Pacific Medical Center, San Francisco), she worked as a clinical ethicist at Beaumont Health in the metro Detroit, Michigan area.

Sarat Vatsavayai, PhD

Specialist

Sarat Vatsavayai received a master of science degree in Human Genetics from Andhra University, India. He then did his doctoral work in the field of Huntington’s disease at the Open University, UK, where he was characterizing a novel mouse model and was trying to find out if DNA repeat instability could modify disease progression. In July 2013, he joined Dr.